Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 126

    1.

    Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.

    Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ; Atrial Arrhythmia Conversion Trial Investigators.

    Circulation. 2008 Mar 25;117(12):1518-25. Epub 2008 Mar 10.PMID: 18332267 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial.

    Cairns JA, Wittes J, Wyse DG, Pogue J, Gent M, Hirsh J, Marler J, Pritchett EL.

    Am Heart J. 2008 Jan;155(1):33-41. Epub 2007 Nov 26. Review.PMID: 18082486 [PubMed - indexed for MEDLINE]Related articles

    3.

    Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.

    Page RL, Pritchett EL, Connolly S, Wilkinson WE; SVA-4 Investigators.

    J Cardiovasc Electrophysiol. 2008 Feb;19(2):172-7. Epub 2007 Oct 3.PMID: 17916138 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.

    Kerr CR, Connolly SJ, Kowey P, Page RL, Pritchett EL, Ruda MY, Ruzyllo W, Wilkinson WE; A-STAR Investigators.

    Am J Cardiol. 2006 Jul 15;98(2):215-8. Epub 2006 May 19.PMID: 16828595 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.

    Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE; A-COMET-I Investigators.

    Am Heart J. 2006 May;151(5):1043-9.PMID: 16644334 [PubMed - indexed for MEDLINE]Related articles

    6.

    Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy.

    Pritchett EL.

    Heart Rhythm. 2004 Jul;1(2 Suppl):B36-9, discussion B39-40. Review.PMID: 15851137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Azimilide for atrial fibrillation: clinical trial results and implications.

    Pritchett EL, Marcello SR.

    Card Electrophysiol Rev. 2003 Sep;7(3):215-9. Review.PMID: 14739716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.

    Pritchett EL, Page RL, Carlson M, Undesser K, Fava G; Rythmol Atrial Fibrillation Trial (RAFT) Investigators.

    Am J Cardiol. 2003 Oct 15;92(8):941-6.PMID: 14556870 [PubMed - indexed for MEDLINE]Related articles

    9.

    Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.

    Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL; Azimilide Supraventricular Arrhythmia Program Investigators.

    Am Heart J. 2003 Sep;146(3):489-93.PMID: 12947368 [PubMed - indexed for MEDLINE]Related articles

    10.

    Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.

    Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators.

    Circulation. 2003 Mar 4;107(8):1141-5.PMID: 12615792 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.

    Pritchett EL, Schulte MC, Schnell D, Marcello SR, Wilkinson WE, Page RL, Connolly SJ; Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.

    J Clin Pharmacol. 2002 Apr;42(4):388-94.PMID: 11936563 [PubMed - indexed for MEDLINE]Related articles

    12.

    Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.

    Page RL, Connolly SJ, Wilkinson WE, Marcello SR, Schnell DJ, Pritchett EL; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators.

    Am Heart J. 2002 Apr;143(4):643-9.PMID: 11923801 [PubMed - indexed for MEDLINE]Related articles

    13.

    Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.

    Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL.

    Am J Cardiol. 2001 Nov 1;88(9):974-9.PMID: 11703992 [PubMed - indexed for MEDLINE]Related articles

    14.

    Modeling recurrent arrhythmias.

    Pritchett EL, Wilkinson WE.

    J Cardiovasc Electrophysiol. 2001 Feb;12(2):131-3. No abstract available. PMID: 11232607 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.

    Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE.

    J Am Coll Cardiol. 2000 Sep;36(3):794-802.PMID: 10987602 [PubMed - indexed for MEDLINE]Related articles

    16.

    Observations on the transition from intermittent to permanent atrial fibrillation.

    Al-Khatib SM, Wilkinson WE, Sanders LL, McCarthy EA, Pritchett EL.

    Am Heart J. 2000 Jul;140(1):142-5.PMID: 10874276 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of dofetilide on survival in patients with supraventricular arrhythmias.

    Pritchett EL, Wilkinson WE.

    Am Heart J. 1999 Nov;138(5 Pt 1):994-7.PMID: 10539835 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical features of Wolff-Parkinson-White syndrome.

    Al-Khatib SM, Pritchett EL.

    Am Heart J. 1999 Sep;138(3 Pt 1):403-13. Review.PMID: 10467188 [PubMed - indexed for MEDLINE]Related articles

    19.

    Evolution and revolution in drug labeling: regulation of antiarrhythmic drugs by the Food and Drug Administration 1962-1996.

    Pritchett EL.

    Pacing Clin Electrophysiol. 1998 Jul;21(7):1457-69.PMID: 9670191 [PubMed - indexed for MEDLINE]Related articles

    20.

    The case for just plain "atrial fibrillation".

    Pritchett EL.

    Pacing Clin Electrophysiol. 1998 Apr;21(4 Pt 1):637-40. No abstract available. PMID: 9584292 [PubMed - indexed for MEDLINE]Related articles

    21.

    Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias.

    Simons GR, Eisenstein EL, Shaw LJ, Mark DB, Pritchett EL.

    Am J Cardiol. 1997 Dec 15;80(12):1551-7.PMID: 9416934 [PubMed - indexed for MEDLINE]Related articles

    22.

    Pharmacologic management of atrial fibrillation.

    Riley RD, Pritchett EL.

    J Cardiovasc Electrophysiol. 1997 Jul;8(7):818-29. Review.PMID: 9255690 [PubMed - indexed for MEDLINE]Related articles

    23.

    Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function.

    Dodds GA 3rd, Wilkinson WE, Greenfield RA, Natale A, Kisslo J, Pritchett EL.

    Am J Cardiol. 1996 Dec 15;78(12):1436-9.PMID: 8970423 [PubMed - indexed for MEDLINE]Related articles

    24.

    Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia.

    Hamer ME, Wilkinson WE, McCarthy EA, Page RL, Pritchett EL.

    Pacing Clin Electrophysiol. 1995 Dec;18(12 Pt 1):2155-7.PMID: 8771127 [PubMed - indexed for MEDLINE]Related articles

    25.

    Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia.

    Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett EL.

    J Am Coll Cardiol. 1995 Apr;25(5):984-8.PMID: 7897142 [PubMed - indexed for MEDLINE]Related articles

    26.

    Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

    McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL.

    Arch Intern Med. 1995 Feb 13;155(3):277-81.PMID: 7832599 [PubMed - indexed for MEDLINE]Related articles

    27.

    Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia.

    Hamer ME, Blumenthal JA, McCarthy EA, Phillips BG, Pritchett EL.

    Am J Cardiol. 1994 Oct 15;74(8):826-9. No abstract available. PMID: 7942563 [PubMed - indexed for MEDLINE]Related articles

    28.

    Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.

    Anderson JL, Platt ML, Guarnieri T, Fox TL, Maser MJ, Pritchett EL.

    Am J Cardiol. 1994 Sep 15;74(6):578-84.PMID: 8074041 [PubMed - indexed for MEDLINE]Related articles

    29.

    Management of atrial fibrillation.

    Matchar D, McCrory D, Pritchett EL.

    Ann Intern Med. 1994 Sep 15;121(6):466-7; author reply 467. No abstract available. PMID: 8053625 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms.

    Hamer ME, Clair WK, Wilkinson WE, Greenfield RA, Pritchett EL, Page RL.

    Pacing Clin Electrophysiol. 1994 May;17(5 Pt 1):938-43.PMID: 7517528 [PubMed - indexed for MEDLINE]Related articles

    31.

    Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

    Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL.

    Circulation. 1994 Jan;89(1):224-7.PMID: 8281651 [PubMed - indexed for MEDLINE]Related articles

    32.

    Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias.

    Pritchett EL, Wilkinson WE, Clair WK, McCarthy EA.

    Am J Cardiol. 1993 Jul 1;72(1):108-10. No abstract available. PMID: 8517417 [PubMed - indexed for MEDLINE]Related articles

    33.

    Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.

    Clair WK, Wilkinson WE, McCarthy EA, Page RL, Pritchett EL.

    Circulation. 1993 Apr;87(4):1114-22.PMID: 8462140 [PubMed - indexed for MEDLINE]Related articles

    34.

    Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.

    Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr, Hawkinson RW, Pritchett EL.

    Am Heart J. 1992 Aug;124(2):381-6.PMID: 1636582 [PubMed - indexed for MEDLINE]Related articles

    35.

    Management of atrial fibrillation.

    Pritchett EL.

    N Engl J Med. 1992 May 7;326(19):1264-71. Review. No abstract available. PMID: 1560803 [PubMed - indexed for MEDLINE]Related articles

    36.

    Treatment of paroxysmal supraventricular tachycardia with oral diltiazem.

    Clair WK, Wilkinson WE, McCarthy EA, Pritchett EL.

    Clin Pharmacol Ther. 1992 May;51(5):562-5.PMID: 1587069 [PubMed - indexed for MEDLINE]Related articles

    37.

    Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.

    Page RL, Wharton JM, Wilkinson WE, Friedman IM, Claypool WD, Karim A, Kowalski KG, McDonald SJ, Gardiner P, Pritchett EL.

    Clin Pharmacol Ther. 1992 Apr;51(4):371-8.PMID: 1563207 [PubMed - indexed for MEDLINE]Related articles

    38.

    New drug application strategies for supraventricular arrhythmias.

    Pritchett EL, Wilkinson WE.

    Clin Pharmacol Ther. 1991 May;49(5):481-7. No abstract available. PMID: 2029826 [PubMed - indexed for MEDLINE]Related articles

    39.

    Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation.

    Weiner HL, McCarthy EA, Pritchett EL.

    J Am Coll Cardiol. 1991 May;17(6):1283-7.PMID: 2016444 [PubMed - indexed for MEDLINE]Related articles

    40.

    Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.

    Pritchett EL, Wilkinson WE.

    Am J Cardiol. 1991 May 1;67(11):976-80.PMID: 1902055 [PubMed - indexed for MEDLINE]Related articles

    41.

    Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.

    Pritchett EL, McCarthy EA, Wilkinson WE.

    Ann Intern Med. 1991 Apr 1;114(7):539-44.PMID: 2001087 [PubMed - indexed for MEDLINE]Related articles

    42.

    Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.

    Pritchett EL, DaTorre SD, Platt ML, McCarville SE, Hougham AJ.

    J Am Coll Cardiol. 1991 Feb;17(2):297-303.PMID: 1899432 [PubMed - indexed for MEDLINE]Related articles

    43.

    Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.

    Henthorn RW, Waldo AL, Anderson JL, Gilbert EM, Alpert BL, Bhandari AK, Hawkinson RW, Pritchett EL.

    Circulation. 1991 Jan;83(1):119-25.PMID: 1898640 [PubMed - indexed for MEDLINE]Related articles

    44.

    Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope.

    Linzer M, Pritchett EL, Pontinen M, McCarthy E, Divine GW.

    Am J Cardiol. 1990 Jul 15;66(2):214-9.PMID: 2371954 [PubMed - indexed for MEDLINE]Related articles

    45.

    Trazodone-related exercise-induced nonsustained ventricular tachycardia.

    Vitullo RN, Wharton JM, Allen NB, Pritchett EL.

    Chest. 1990 Jul;98(1):247-8.PMID: 2361400 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry.

    Hurwitz JL, German LD, Packer DL, Wharton JM, McCarthy EA, Wilkinson WE, Prystowsky EN, Pritchett EL.

    Pacing Clin Electrophysiol. 1990 Jun;13(6):705-10.PMID: 1695348 [PubMed - indexed for MEDLINE]Related articles

    47.

    Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial.

    Pratt CM, Brater DC, Harrell FE Jr, Kowey PR, Leier CV, Lowenthal DT, Messerli F, Packer M, Pritchett EL, Ruskin JN.

    Am J Cardiol. 1990 Jan 1;65(1):103-5. No abstract available. PMID: 1688479 [PubMed - indexed for MEDLINE]Related articles

    49.

    Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation.

    Greer GS, Wilkinson WE, McCarthy EA, Pritchett EL.

    Am J Cardiol. 1989 Aug 1;64(5):339-42.PMID: 2756878 [PubMed - indexed for MEDLINE]Related articles

    50.

    Surgical procedures on the atrioventricular node.

    Pritchett EL.

    Mayo Clin Proc. 1988 Oct;63(10):1050-2. No abstract available. PMID: 3172855 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...